Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...

Researchers suggest tunneling may reflect a conserved strategy adopted by specialized migratory cell types in dense tissues.

Using sensors and a light-activated drug, the team mapped neural pathways used by endogenous opioids to send pain relief ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

This eBook brings together a curated collection of resources to help you break through the constraints of throughput, ...

Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.

Minimal residual disease (MRD) continues to be a central focus at the AACR meeting. The small numbers of cancer cells that ...

The customizable platform used AAVs to deliver genetic cargo that induced the production of three anti-inflammatory cytokines ...

Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

Daraxonrasib improved survival in metastatic pancreatic cancer in Phase III, signaling meaningful progress for therapies targeting RAS‑driven disease.

In this virtual summit GEN invites you to watch a superb line-up of presenters covering key topics in the world of multiomics, spatial biology, and NGS.

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.